{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T02:37:07Z","timestamp":1778553427486,"version":"3.51.4"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["U54 AI057156"],"award-info":[{"award-number":["U54 AI057156"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.virol.2009.09.008","type":"journal-article","created":{"date-parts":[[2009,10,3]],"date-time":"2009-10-03T19:45:46Z","timestamp":1254599146000},"page":"97-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["New classes of orthopoxvirus vaccine candidates by functionally screening a synthetic library for protective antigens"],"prefix":"10.1016","volume":"395","author":[{"given":"Alexandre","family":"Borovkov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Mitch","family":"Magee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrey","family":"Loskutov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A.","family":"Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Selinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Zsemlye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Rick","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.virol.2009.09.008_bib1","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1128\/JVI.74.8.3815-3831.2000","article-title":"The genome of fowlpox virus","volume":"74","author":"Afonso","year":"2000","journal-title":"J. Virol."},{"issue":"Pt. 4","key":"10.1016\/j.virol.2009.09.008_bib2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1099\/0022-1317-80-4-949","article-title":"Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors","volume":"80","author":"Alcami","year":"1999","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.virol.2009.09.008_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/viro.1998.9123","article-title":"The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses","volume":"244","author":"Antoine","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.virol.2009.09.008_bib4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.0105-2896.2004.00143.x","article-title":"Expression library immunization to discover and improve vaccine antigens","volume":"199","author":"Barry","year":"2004","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/j.virol.2009.09.008_bib5","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.4049\/jimmunol.159.12.5802","article-title":"Distinct biochemical signals characterize agonist- and altered peptide ligand-induced differentiation of naive CD4+ T cells into Th1 and Th2 subsets","volume":"159","author":"Boutin","year":"1997","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.virol.2009.09.008_bib6","first-page":"80","article-title":"Poxvirus pathogenesis","volume":"55","author":"Buller","year":"1991","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"5","key":"10.1016\/j.virol.2009.09.008_bib7","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1128\/JVI.80.5.2127-2140.2006","article-title":"Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles","volume":"80","author":"Chung","year":"2006","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2009.09.008_bib8","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1128\/JVI.01280-06","article-title":"Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicry","volume":"81","author":"Cornberg","year":"2007","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virol.2009.09.008_bib9","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.4049\/jimmunol.178.3.1654","article-title":"Cowpox virus evades CTL recognition and inhibits the intracellular transport of MHC class i molecules","volume":"178","author":"Dasgupta","year":"2007","journal-title":"J. Immunol."},{"issue":"18","key":"10.1016\/j.virol.2009.09.008_bib10","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1128\/JVI.79.18.11724-11733.2005","article-title":"Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice","volume":"79","author":"Davies","year":"2005","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2009.09.008_bib11","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1128\/jvi.70.4.2627-2631.1996","article-title":"Human cytotoxic T-cell memory: long-lived responses to vaccinia virus","volume":"70","author":"Demkowicz","year":"1996","journal-title":"J. Virol."},{"issue":"5-6","key":"10.1016\/j.virol.2009.09.008_bib12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1744-313X.1988.tb00437.x","article-title":"Genetic control of C3 production by the S region of the mouse MHC","volume":"15","author":"Dieli","year":"1988","journal-title":"J. Immunogenet."},{"issue":"11","key":"10.1016\/j.virol.2009.09.008_bib14","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1286-4579(03)00194-1","article-title":"Variola virus immune evasion proteins","volume":"5","author":"Dunlop","year":"2003","journal-title":"Microbes. Infect."},{"issue":"7","key":"10.1016\/j.virol.2009.09.008_bib15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.virol.2009.09.008_bib16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1089\/vim.2006.0091","article-title":"CD4+ T cells play a pivotal role in the control of cowpox virus infection in mice","volume":"20","author":"Ferrier-Rembert","year":"2007","journal-title":"Viral. Immunol."},{"issue":"4","key":"10.1016\/j.virol.2009.09.008_bib17","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1128\/IAI.70.4.2022-2028.2002","article-title":"Mucosal or parental administration of mircosphere-associated Bacillus anthracis protective antigen protects against anthrax in mice","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.virol.2009.09.008_bib18","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/IAI.70.3.1653-1656.2002","article-title":"A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.virol.2009.09.008_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.virol.2008.04.003","article-title":"Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine","volume":"377","author":"Golden","year":"2008","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.virol.2009.09.008_bib20","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.virol.2009.09.008_bib21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3201\/eid0504.990415","article-title":"Smallpox: clinical and epidemiologic features","volume":"5","author":"Henderson","year":"1999","journal-title":"Emerg. Infect. Dis."},{"issue":"4","key":"10.1016\/j.virol.2009.09.008_bib22","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.4049\/jimmunol.177.4.2552","article-title":"Subunit recombinant vaccine protects against monkeypox","volume":"177","author":"Heraud","year":"2006","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.virol.2009.09.008_bib23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/viro.1999.0096","article-title":"DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge","volume":"266","author":"Hooper","year":"2000","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2009.09.008_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.virol.2009.09.008_bib25","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J. Virol."},{"issue":"7346","key":"10.1016\/j.virol.2009.09.008_bib26","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/bmj.324.7346.1157\/a","article-title":"Immunity conferred by smallpox vaccine. How long does immunity last?","volume":"324","author":"Jacobs","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.virol.2009.09.008_bib27","volume":"1 vols","author":"Janeway","year":"2005"},{"issue":"11","key":"10.1016\/j.virol.2009.09.008_bib28","doi-asserted-by":"crossref","first-page":"7550","DOI":"10.4049\/jimmunol.175.11.7550","article-title":"Diversity in the acute CD8 T cell response to vaccinia virus in humans","volume":"175","author":"Jing","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2009.09.008_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0042-6822(62)90172-1","article-title":"The purification of four strains of poxvirus","volume":"18","author":"Joklik","year":"1962","journal-title":"Virology"},{"key":"10.1016\/j.virol.2009.09.008_bib30","doi-asserted-by":"crossref","unstructured":"Karron, R. A., Wright, P. F., Belshe, R. B., Thumar, B., Casey, R., Newman, F., Polack, F. P., Randolph, V. B., Deatly, A., Hackell, J., Gruber, W., Murphy, B. R., and Collins, P. L. (2005). Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. J. Infect. Dis. 191(7), 1093-104.","DOI":"10.1086\/427813"},{"issue":"14","key":"10.1016\/j.virol.2009.09.008_bib31","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.1128\/JVI.00353-08","article-title":"Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice","volume":"82","author":"Kaufman","year":"2008","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2009.09.008_bib32","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3201\/eid0504.990429","article-title":"Current status of smallpox vaccine","volume":"5","author":"LeDuc","year":"1999","journal-title":"Emerg. Infect. Dis."},{"issue":"21","key":"10.1016\/j.virol.2009.09.008_bib33","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1128\/JVI.79.21.13454-13462.2005","article-title":"Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge","volume":"79","author":"Lustig","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2009.09.008_bib34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.virol.2008.10.041","article-title":"The role of the cowpox virus crmA gene during intratracheal and intradermal infection of C57BL\/6 mice","volume":"384","author":"MacNeill","year":"2009","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.virol.2009.09.008_bib35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrmicro1099","article-title":"Poxvirus tropism","volume":"3","author":"McFadden","year":"2005","journal-title":"Nat. Rev. Micro."},{"issue":"9508","key":"10.1016\/j.virol.2009.09.008_bib36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(06)68143-9","article-title":"Smallpox","volume":"367","author":"Moore","year":"2006","journal-title":"Lancet"},{"issue":"5013","key":"10.1016\/j.virol.2009.09.008_bib37","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1126\/science.2047875","article-title":"Vaccinia virus: a tool for research and vaccine development","volume":"252","author":"Moss","year":"1991","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.virol.2009.09.008_bib38","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nbt1215","article-title":"A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus","volume":"24","author":"Moutaftsi","year":"2006","journal-title":"Nat. Biotechnol."},{"issue":"20","key":"10.1016\/j.virol.2009.09.008_bib39","doi-asserted-by":"crossref","first-page":"11936","DOI":"10.1074\/jbc.271.20.11936","article-title":"Domain structure of the vaccinia virus mRNA capping enzyme","volume":"271","author":"Myette","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.virol.2009.09.008_bib40","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.virol.2008.08.009","article-title":"Vaccinia virus entry\/fusion complex subunit A28 is a target of neutralizing and protective antibodies","volume":"380","author":"Nelson","year":"2008","journal-title":"Virology"},{"issue":"19","key":"10.1016\/j.virol.2009.09.008_bib41","doi-asserted-by":"crossref","first-page":"9822","DOI":"10.1128\/JVI.00987-06","article-title":"Vaccinia virus G9 protein is an essential component of the poxvirus entry-fusion complex","volume":"80","author":"Ojeda","year":"2006","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2009.09.008_bib42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1128\/JVI.80.1.51-61.2006","article-title":"Entry of vaccinia virus and cell\u2013cell fusion require a highly conserved cysteine-rich membrane protein encoded by the A16L gene","volume":"80","author":"Ojeda","year":"2006","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.virol.2009.09.008_bib43","doi-asserted-by":"crossref","first-page":"7193","DOI":"10.4049\/jimmunol.180.11.7193","article-title":"Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve","volume":"180","author":"Oseroff","year":"2008","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.virol.2009.09.008_bib44","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jaci.2006.09.037","article-title":"Smallpox vaccines: past, present, and future","volume":"118","author":"Parrino","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.virol.2009.09.008_bib45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1586\/14760584.6.1.87","article-title":"Understanding orthopoxvirus interference with host immune responses to inform novel vaccine design","volume":"6","author":"Pickup","year":"2007","journal-title":"Expert. Rev. Vaccines"},{"issue":"6","key":"10.1016\/j.virol.2009.09.008_bib46","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1084\/jem.20062363","article-title":"Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses","volume":"204","author":"Precopio","year":"2007","journal-title":"J. Exp. Med."},{"issue":"25-26","key":"10.1016\/j.virol.2009.09.008_bib47","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1016\/j.vaccine.2004.02.034","article-title":"Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB\/c mice from a lethal intranasal poxvirus challenge","volume":"22","author":"Pulford","year":"2004","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.virol.2009.09.008_bib48","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virol.2006.07.017","article-title":"Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen","volume":"355","author":"Sakhatskyy","year":"2006","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2009.09.008_bib49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.virol.2007.09.029","article-title":"Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens","volume":"371","author":"Sakhatskyy","year":"2008","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virol.2009.09.008_bib50","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1006\/viro.1998.9039","article-title":"The genomic sequence analysis of the left and right species-specific terminal region of a cowpox virus strain reveals unique sequences and a cluster of intact ORFs for immunomodulatory and host range proteins","volume":"243","author":"Shchelkunov","year":"1998","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virol.2009.09.008_bib51","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/viro.1999.0086","article-title":"Alastrim Smallpox variola minor virus genome DNA sequences","volume":"266","author":"Shchelkunov","year":"2000","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2009.09.008_bib52","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-9433-4-2","article-title":"The future of smallpox vaccination: is MVA the key?","volume":"4","author":"Slifka","year":"2005","journal-title":"Med. Immunol."},{"key":"10.1016\/j.virol.2009.09.008_bib53","first-page":"521","article-title":"Smallpox: anything to declare?","volume":"2","author":"Smith","year":"2002","journal-title":"Nat. Rev."},{"issue":"7","key":"10.1016\/j.virol.2009.09.008_bib54","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1089\/104454999315079","article-title":"Genetic live vaccines mimic the antigenicity but not pathogenicity of live viruses","volume":"18","author":"Sykes","year":"1999","journal-title":"DNA Cell. Biol."},{"issue":"6","key":"10.1016\/j.virol.2009.09.008_bib55","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1128\/JVI.77.6.3418-3429.2003","article-title":"Vaccinia virus G7L protein interacts with the A30L protein and is required for association of viral membranes with dense viroplasm to form immature virions","volume":"77","author":"Szajner","year":"2003","journal-title":"J. Virol."},{"issue":"6365","key":"10.1016\/j.virol.2009.09.008_bib56","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/356152a0","article-title":"Genetic immunization is a simple method for eliciting an immune response","volume":"356","author":"Tang","year":"1992","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.virol.2009.09.008_bib57","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.virol.2007.01.001","article-title":"Vaccination with Venezuelan equine encephalitis replicons encoding cowpox virus structural proteins protects mice from intranasal cowpox virus challenge","volume":"362","author":"Thornburg","year":"2007","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2009.09.008_bib58","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1084\/jem.20041912","article-title":"Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines","volume":"201","author":"Tscharke","year":"2005","journal-title":"J. Exp. Med."},{"issue":"13","key":"10.1016\/j.virol.2009.09.008_bib59","doi-asserted-by":"crossref","first-page":"7544","DOI":"10.1073\/pnas.95.13.7544","article-title":"Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope","volume":"95","author":"Vanderplasschen","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.virol.2009.09.008_bib60","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.micinf.2005.02.004","article-title":"Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccines","volume":"7","author":"Viner","year":"2005","journal-title":"Microbes. Infect."},{"issue":"12","key":"10.1016\/j.virol.2009.09.008_bib61","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.vaccine.2005.11.022","article-title":"Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine","volume":"24","author":"Vollmar","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.virol.2009.09.008_bib62","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/QCO.0b013e3282f44c74","article-title":"Cowpox virus infection: an emerging health threat","volume":"21","author":"Vorou","year":"2008","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"29-30","key":"10.1016\/j.virol.2009.09.008_bib63","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1016\/j.vaccine.2008.04.073","article-title":"Heterologous HA DNA vaccine prime\u2014inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.virol.2009.09.008_bib64","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJMoa050824","article-title":"Efficacy of an acellular pertussis vaccine among adolescents and adults","volume":"353","author":"Ward","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.virol.2009.09.008_bib65","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nm916","article-title":"Clonal vaccinia virus grown in cell culture as a new smallpox vaccine","volume":"9","author":"Weltzin","year":"2003","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.virol.2009.09.008_bib66","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.vaccine.2006.09.046","article-title":"An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies","volume":"25","author":"Wiser","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.virol.2009.09.008_bib67","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/viro.1995.1378","article-title":"A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies","volume":"211","author":"Wolffe","year":"1995","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.virol.2009.09.008_bib68","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.vaccine.2006.10.009","article-title":"A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost","volume":"25","author":"Xiao","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.virol.2009.09.008_bib69","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.20071854","article-title":"The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination","volume":"205","author":"Xu","year":"2008","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.virol.2009.09.008_bib70","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0168-1702(95)00025-L","article-title":"The vaccinia virus J5L open reading frame encodes a polypeptide expressed late during infection and required for viral multiplication","volume":"37","author":"Zajac","year":"1995","journal-title":"Virus Res."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268220900556X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268220900556X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:02:48Z","timestamp":1758585768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004268220900556X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S004268220900556X"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2009.09.008","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New classes of orthopoxvirus vaccine candidates by functionally screening a synthetic library for protective antigens","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2009.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}